Square

Square Pharmaceuticals is the leading pharmaceutical company in Bangladesh and a significant player in the global generic medicine market. Founded in 1958, the company produces a vast array of high-quality generic products across nearly all major therapeutic classes, including cardiovascular, gastrointestinal, and anti-infectives. It operates state-of-the-art manufacturing facilities that have received approvals from stringent global regulatory bodies such as the US FDA and UK MHRA. Beyond traditional small molecules, the company has expanded into specialized areas like insulin production, cephalosporins, and herbal medicines. Square Pharmaceuticals is publicly traded on the Dhaka Stock Exchange and exports its products to over 40 countries worldwide. The company is recognized for its commitment to affordable healthcare and its role as a pioneer in the South Asian pharmaceutical industry.